Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use - Test2 - elhamkhani - TriplyDB

Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use

Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use

http://www.wikidata.org/entity/Q28469104

about

Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis Plasmodium falciparum susceptibility to antimalarial drugs: global data issued from the Pasteur Institutes international network Parasite polymorphism and severe malaria in Dakar (Senegal): a West African urban area Effects of point mutations in Plasmodium falciparum dihydrofolate reductase and dihydropterate synthase genes on clinical outcomes and in vitro susceptibility to sulfadoxine and pyrimethamine Impact of changing drug treatment and malaria endemicity on the heritability of malaria phenotypes in a longitudinal family-based cohort study Surveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countries Risk factors for Plasmodium falciparum gametocyte positivity in a longitudinal cohort Genetic determination and linkage mapping of Plasmodium falciparum malaria related traits in Senegal.Population diversity and antibody selective pressure to Plasmodium falciparum MSP1 block2 locus in an African malaria-endemic setting Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali.Association of antibody responses to the conserved Plasmodium falciparum merozoite surface protein 5 with protection against clinical malaria Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine.Multinormal in vitro distribution model suitable for the distribution of Plasmodium falciparum chemosusceptibility to doxycycline.Human-to-mosquito transmission efficiency increases as malaria is controlled.Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013-2014 malaria season.Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs Media, health workers, and policy makers' relationship and their impact on antimalarial policy adoption: a population genetics perspective.Quinine-resistant malaria in traveler returning from Senegal, 2007 Inhibitory effect of novel iron chelator, 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) and green tea extract on growth of Plasmodium falciparum.Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005.Inflammatory cytokine and humoral responses to Plasmodium falciparum glycosylphosphatidylinositols correlates with malaria immunity and pathogenesis.Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011 Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agents Population genetics analysis during the elimination process of Plasmodium falciparum in Djibouti.An in vivo and in vitro model of Plasmodium falciparum rosetting and autoagglutination mediated by varO, a group A var gene encoding a frequent serotype.Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006 Monitoring antimalarial drug resistance: Applying lessons learned from the past in a fast-moving present.A link between poor quality antimalarials and malaria drug resistance?World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibility.Investigating the prevalence of transfusion transmission of Plasmodium within a hyperendemic blood donation system.Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.Dihydrofolate reductase I164L mutation in Plasmodium falciparum, Madagascar.

P2860

Q26795623-DA44FE5F-57CC-4649-9FC2-A16B751EB514 Q26860875-2E8EE11B-4C59-4EAD-A000-09E654A78C23 Q28473367-00DF1665-B256-4058-A414-7A14F9C09EB8 Q28476005-77FA64DB-396B-426B-B43D-0A5B07FF858D Q28477767-7A6FE199-32DF-4059-B143-65D4D91B6FC6 Q28534753-A73EF77D-6DCE-4502-BE93-AE68B44FB079 Q28545275-61DAD164-FFFB-4EC0-9451-12ED78C4EA50 Q33330289-6A29EDF9-D5E8-4A02-B9D2-87EC9E36E8EC Q33510819-C8FD07FE-BF5F-4615-973C-EF2A7F8C9F9B Q33645358-64082FC0-C131-4BCD-971B-0C600AE241D8 Q33927906-3DCFD12D-875F-47DD-B86E-C3BC9DD9D5B6 Q34014169-CBD8DE27-0BB1-449F-8F5F-2E319DEDCF06 Q34601191-4BE14CFD-AF79-4D9D-9F5B-BD6C7605FC82 Q35022983-06A3D5F8-B9BD-4794-8E75-16FF23BC78FA Q35101288-F0720193-1584-44E7-BF80-9C5B169ADA6A Q35533577-A1C8972A-FB43-41CD-97B8-06DBF65460AB Q35755266-799F8AD0-9502-4AE7-9DD0-3C2A66D28C9B Q35877446-50CFAC39-37A2-4326-931D-64E38D87E8C3 Q36110783-4941F6CD-1F00-427F-8E71-5B0B87AD79D9 Q36316217-D75A5CE5-ADE7-49FD-9238-5BE37EC005FE Q36422626-0E9AB7AC-CE35-4A20-9407-07BA62BE37E6 Q36621046-11FC5ADF-E64B-4BC0-82C8-3B75C9982232 Q36643101-E532285D-CE3A-4337-88F9-2498370D7E7F Q36711959-B85A8276-9380-4137-8EC5-6EBCB951585F Q36914067-3B66206D-4DC9-4FFF-9DF3-1EA3DE7C8E1E Q36937401-0D647BB6-E423-44DE-81AA-BAAD717F236E Q36974515-B09F93E1-9C39-4799-BA1E-D4D30E3D1304 Q37188734-8FBDE204-2644-459E-BBB5-A1ADAF25D168 Q37390583-05948E8F-D403-4FCA-9FA7-DB91D83FED86 Q39300954-C6083B1F-D00D-4633-B574-46D89E91F0A0 Q41410017-411DF9AA-AFB6-433F-88D0-2B8C452778E2 Q41927939-B1A9FE8E-7BD5-4F39-A211-68FBFD5367AB Q41929191-45CEBCFB-0FFC-4DC1-80E1-48C1C9498740 Q43230300-379382B8-B257-4C82-885B-9E3659BB819E

P2860

Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use

http://www.wikidata.org/entity/Q28469104

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Rapid dissemination of Plasmod ...... ly controlled antimalarial use

@ast

Rapid dissemination of Plasmod ...... ly controlled antimalarial use

@en

Rapid dissemination of Plasmod ...... ly controlled antimalarial use

@nl

type

label

Rapid dissemination of Plasmod ...... ly controlled antimalarial use

@ast

Rapid dissemination of Plasmod ...... ly controlled antimalarial use

@en

Rapid dissemination of Plasmod ...... ly controlled antimalarial use

@nl

prefLabel

Rapid dissemination of Plasmod ...... ly controlled antimalarial use

@ast

Rapid dissemination of Plasmod ...... ly controlled antimalarial use

@en

Rapid dissemination of Plasmod ...... ly controlled antimalarial use

@nl

P1433

Q28469104-EA2EAE1D-4634-44B6-873C-E18EFDD82F62

P1476

Q28469104-EBE98418-E46D-45E0-85BF-39DA611D9FEA

P2093

Q28469104-45D2BE8C-E721-43EC-B453-07CA77CA9C16

Q28469104-6423C357-B76F-4347-A2F9-E7EEE160C3FB

Q28469104-7D6FFCE9-4251-4557-B8CE-EF51EF79C657

Q28469104-88985672-F0C5-4E6C-85B8-DC9E06FA447E

Q28469104-8EC3869F-638C-441D-999A-EE0AD08B0BBF

Q28469104-DAA92E67-6E0B-4278-B383-07D06E75975C

Q28469104-F686A9E1-E9EF-467F-8E0B-061C15A32D6B

Q28469104-F7CCA509-79A6-496E-A237-EEFCBF9F67C6

Q28469104-F802019B-318B-4AEC-A103-1E87EB395B76

Q28469104-F9B15893-603B-426F-845F-DD441A0911A5

P2860

Q28469104-042D26DB-E246-424C-86A7-EF9222795082

Q28469104-10C4FBAF-2D81-4482-8846-42704D9304B5

Q28469104-11AC7CDE-1DDB-4773-8C92-968AEA7898D3

Q28469104-1683AD64-723D-407D-9F4F-3E599785B465

Q28469104-25C16C25-697B-467D-B235-6F542CD889E5

Q28469104-26854A36-0502-49D8-8497-BD537A812AE0

Q28469104-2820E34A-E16E-4E5B-936D-3663F091BB71

Q28469104-2E512E10-5E40-482E-B20E-623CC8F94960

Q28469104-414E2A6B-90DA-478D-95AB-CB5043E428FE

Q28469104-4217B196-4DFC-47AC-8446-27BDA9ECF172

P304

Q28469104-2A2D74D0-07F1-488D-9D0E-FD0BA8455F96

P31

Q28469104-5524914D-1770-467A-993D-21E9B0FEBEFD

P356

Q28469104-E0127DAB-9E8F-4C03-8A8B-7663C57FFBCB

P407

Q28469104-399B3908-CD95-4DEB-BBFB-11942F12ACCC

P433

Q28469104-A1993567-3249-4889-8311-4C6D0143DDB2

P478

Q28469104-D67AEE11-057D-4189-B8DC-EE7236063B5E

P50

Q28469104-2A977AB5-1EF1-4EB3-BD4C-DB52A2D5536E

Q28469104-39E29C31-35E9-4926-BE0A-32602546FD66

Q28469104-4C8B5758-958E-42A6-8BC0-02189609712E

Q28469104-77400BD2-3FC0-4510-9768-8307C02355C7

Q28469104-A68113E3-EACA-4CD5-AC41-97C58C72B456

Q28469104-AB027948-AB36-4EC0-8D51-8C7C587641A2

Q28469104-AF2A2B5B-F906-4924-8000-6DEC2C145DD2

Q28469104-D1491B87-7757-4BAD-9FDD-025428A3B4C7

Q28469104-F6DCFD63-51D6-4AA4-A317-B5CBB60C8573

P577

Q28469104-17A4FD58-8391-4EC8-82A4-7C5C80C538A0

P5875

Q28469104-FC56D094-D80C-4DDE-9DB5-F7F48FF46C71

P698

Q28469104-C4E06B9F-DFFB-4EF6-B941-87B4BC54A315

P921

Q28469104-284ACCB6-978A-493F-92B5-0CB73BBC42F4

Q28469104-D4594840-104E-495D-A940-46E590281E48

P932

Q28469104-F17CD336-DE4E-4F86-A8DC-745C8C720AFA

P356

JOURNAL.PONE.0000139

P1433

P1476

Rapid dissemination of Plasmod ...... ly controlled antimalarial use

@en

P2093

André Spiegel

http://www.w3.org/2001/XMLSchema#string

Emmanuel Bischoff

http://www.w3.org/2001/XMLSchema#string

Jean François Trape

http://www.w3.org/2001/XMLSchema#string

Jintana Patarapotikul

http://www.w3.org/2001/XMLSchema#string

Laurence Marrama

http://www.w3.org/2001/XMLSchema#string

Marie-Thérèse Ekala

http://www.w3.org/2001/XMLSchema#string

Micheline Guillotte

http://www.w3.org/2001/XMLSchema#string

Nitchakarn Noranate

http://www.w3.org/2001/XMLSchema#string

Rémy Durand

http://www.w3.org/2001/XMLSchema#string

Thierry Fandeur

http://www.w3.org/2001/XMLSchema#string

P2860

Antimalarial drug resistance

Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether

Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria.

Estimation of average heterozygosity and genetic distance from a small number of individuals

Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum

Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance

Novel antifolate resistant mutations of Plasmodium falciparum dihydrofolate reductase selected in Escherichia coli.

Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum.

A molecular marker for chloroquine-resistant falciparum malaria.

Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum.

P304

e139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0000139

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Frédéric Ariey

Jacques Le Bras

Odile Mercereau-Puijalon

Christiane Bouchier

Christophe Rogier

Sandrine Cojean

P577

2007-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6595434

http://www.w3.org/2001/XMLSchema#string

P698

17206274

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

1764034

http://www.w3.org/2001/XMLSchema#string